Notice2022-19243
National Institute on Drug Abuse; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 7, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 172 (Wednesday, September 7, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 172 (Wednesday, September 7, 2022)]
[Notices]
[Pages 54707-54708]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19243]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, NIDA.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(6), Title
5 U.S.C., as amended for the review, discussion, and evaluation of
individual grant applications conducted by the National Institute on
Drug Abuse, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, NIDA.
Date: October 25-26, 2022.
Closed: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Institute on Drug Abuse, NIH, Biomedical
Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Contact Person: Deon M. Harvey, Ph.D., Management Analyst,
Office of the Scientific Director, National Institute on Drug Abuse,
251 Bayview Boulevard, Room 04A314, Baltimore, MD 21224, (443) 740-
2466, <a href="/cdn-cgi/l/email-protection#e88c8d8786c680899a9e8d91a8868180c68f879e"><span class="__cf_email__" data-cfemail="1377767c7d3d7b726165766a537d7a7b3d747c65">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
[[Page 54708]]
Dated: September 1, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19243 Filed 9-6-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 7, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.